ARTICLE | Company News
Addrenex, Shionogi deal
November 23, 2009 8:00 AM UTC
Shionogi's Sciele Pharma Inc. subsidiary will acquire partner Addrenex for about $29 million in cash. Sciele already has rights to Addrenex's Clonicel clonidine to treat ADHD, Jenloga XR once-daily ...